Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 01:56 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial
NCT01876043 · Institut Bergonié · PHASE2 · terminated · last registry update 2021-01-25 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Institut Bergonié |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against EEF1A2 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-09-24Results posted on the registry: PharmaMar, Plitidepsin 1.5 mg/day + Plitidepsin 2.0 mg/day (NCT04382066)
- 2021-03-05Phase 3 first posted: PharmaMar, Plitidepsin + Dexamethasone (NCT04784559)
- 2020-12-02Results posted on the registry: PharmaMar, plitidepsin + Bortezomib (NCT03117361)
- 2020-12-02Also stopped (terminated): PharmaMar, plitidepsin + Bortezomib (NCT03117361)
- 2020-11-24Results posted on the registry: PharmaMar, Aplidin (plitidepsin) (NCT00780975)
- 2020-11-24Also stopped (terminated): PharmaMar, Aplidin (plitidepsin) (NCT00780975)
- 2020-10-22Results posted on the registry: PharmaMar, Plitidepsin + Dexamethasone (NCT01102426)
- 2020-10-14Results posted on the registry: PharmaMar, plitidepsin (NCT03070964)
- 2020-10-14Also stopped (terminated): PharmaMar, plitidepsin (NCT03070964)
- 2020-10-12Results posted on the registry: PharmaMar, Plitidepsin + Bortezomib (NCT02100657)
- 2020-10-12Results posted on the registry: PharmaMar, APLIDIN (plitidepsin) (NCT01149681)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision